IRIS
SONVICO, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.348
AS - Asia 9.502
EU - Europa 6.731
SA - Sud America 1.308
Continente sconosciuto - Info sul continente non disponibili 454
AF - Africa 427
OC - Oceania 34
Totale 30.804
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.931
SG - Singapore 3.339
CN - Cina 2.535
IT - Italia 1.457
VN - Vietnam 1.385
IE - Irlanda 1.099
BR - Brasile 971
SE - Svezia 869
FI - Finlandia 738
HK - Hong Kong 675
DE - Germania 577
FR - Francia 488
BD - Bangladesh 429
UA - Ucraina 384
NL - Olanda 297
ZA - Sudafrica 290
TR - Turchia 279
GB - Regno Unito 244
CA - Canada 221
IN - India 180
RU - Federazione Russa 139
AR - Argentina 118
KR - Corea 91
AT - Austria 79
ID - Indonesia 76
IQ - Iraq 76
MX - Messico 75
JP - Giappone 68
ES - Italia 62
CO - Colombia 57
EC - Ecuador 50
PL - Polonia 50
BE - Belgio 45
TW - Taiwan 43
PK - Pakistan 40
TH - Thailandia 40
CZ - Repubblica Ceca 38
VE - Venezuela 36
PH - Filippine 34
UZ - Uzbekistan 30
PT - Portogallo 29
AU - Australia 26
CR - Costa Rica 25
MA - Marocco 24
MY - Malesia 22
CH - Svizzera 21
PY - Paraguay 21
CL - Cile 20
JM - Giamaica 19
SA - Arabia Saudita 19
DZ - Algeria 18
TN - Tunisia 17
HN - Honduras 16
JO - Giordania 16
AE - Emirati Arabi Uniti 15
IL - Israele 15
LT - Lituania 15
CI - Costa d'Avorio 14
IR - Iran 14
RS - Serbia 14
EU - Europa 13
KE - Kenya 13
PE - Perù 12
UY - Uruguay 12
GT - Guatemala 11
HU - Ungheria 11
NP - Nepal 11
SC - Seychelles 11
AZ - Azerbaigian 10
BO - Bolivia 10
EG - Egitto 10
KZ - Kazakistan 10
AL - Albania 9
DK - Danimarca 9
EE - Estonia 9
ET - Etiopia 9
HR - Croazia 9
LB - Libano 9
NI - Nicaragua 9
RO - Romania 9
NZ - Nuova Zelanda 8
MD - Moldavia 7
SY - Repubblica araba siriana 7
DO - Repubblica Dominicana 6
PA - Panama 6
SN - Senegal 6
BG - Bulgaria 5
OM - Oman 5
PR - Porto Rico 5
SV - El Salvador 5
BH - Bahrain 4
GA - Gabon 4
NO - Norvegia 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BY - Bielorussia 3
CW - ???statistics.table.value.countryCode.CW??? 3
GE - Georgia 3
GP - Guadalupe 3
Totale 30.316
Salva come PNG Salva come JPEG
Città #
Singapore 1.636
Ashburn 1.603
San Jose 1.112
Dublin 1.081
Chandler 914
Santa Clara 897
Hong Kong 626
Beijing 603
Council Bluffs 449
Jacksonville 436
Dallas 434
Ho Chi Minh City 406
Parma 362
Dearborn 326
Ann Arbor 324
Boardman 296
Hanoi 281
Johannesburg 262
Los Angeles 241
New York 233
Nanjing 224
Lauterbourg 186
Izmir 185
Princeton 179
Shanghai 177
Hefei 145
Milan 139
Wilmington 123
Munich 116
Helsinki 104
Columbus 101
San Mateo 94
Buffalo 91
São Paulo 82
Bremen 81
Moscow 81
Toronto 81
Shenyang 79
Seattle 78
Rome 77
Nanchang 73
Woodbridge 71
Guangzhou 69
Chicago 67
Seoul 66
Da Nang 65
Turku 62
Houston 61
Des Moines 58
Hebei 58
The Dalles 58
Haiphong 56
Vienna 56
Kunming 55
Bologna 53
Atlanta 49
Brooklyn 49
Frankfurt am Main 48
Jakarta 48
Jiaxing 48
Dong Ket 47
North Bergen 47
Tianjin 47
Orem 46
Jinan 44
London 43
Phoenix 43
Reggio Emilia 42
Tokyo 42
Changsha 41
Montreal 37
Brussels 36
San Francisco 34
Warsaw 34
Ferrara 33
Groningen 33
Fremont 31
Marseille 31
Naples 30
Pune 30
Shenzhen 30
Belo Horizonte 29
Nuremberg 28
Stockholm 28
Brno 27
Amsterdam 26
Baghdad 24
Brasília 24
Rio de Janeiro 24
Falls Church 23
Grafing 23
Mexico City 23
Tashkent 23
Denver 22
Mumbai 22
Norwalk 22
Washington 22
Zhengzhou 22
Konyaalti 21
Charlotte 20
Totale 17.369
Salva come PNG Salva come JPEG
Nome #
Chimeral agglomerates of microparticles for the administration of caffeine nasal powders 408
Clinically Relevant Characterization and Comparison of Ryaltris and Other Anti-Allergic Nasal Sprays 380
Development of a nasal spray based on cyclodextrin/hydrophobically-modified hydroxypropyl-methyl cellulose for the prevention of viral respiratory infections 362
Curcumin and Quercetin-Loaded Lipid Nanocarriers: Development of Omega-3 Mucoadhesive Nanoemulsions for Intranasal Administration 275
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 262
Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model 257
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 249
Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model 248
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 245
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 236
Nano-adjuvanted dry powder vaccine for the mucosal immunization against airways pathogens 224
Anti-Inflammatory Properties of Statin-Loaded Biodegradable Lecithin/Chitosan Nanoparticles: A Step Toward Nose-to-Brain Treatment of Neurodegenerative Diseases 222
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 220
The Impact of Possible Misuses Conditions on in Vitro Performance of NEXThaler in Comparison with Ellipta Inhaler 218
Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery 218
Agglomerated Oral Dosage Forms of Artemisinin/β-cyclodextrin Spray-dried Primary Microparticles Showing Increased Dissolution Rate and Bioavailability 217
Opportunity and challenges of nasal powders: Drug formulation and delivery 215
Agglomerates Containing Pantoprazole Microparticles: Modulating the Drug Release 211
Identifying contact-mediated, localized toxic effects of MWCNT aggregates on epithelial monolayers: A single-cell monitoring toxicity assay 209
A respirable HPV-L2 dry-powder vaccine with GLA as amphiphilic lubricant and immune-adjuvant 207
Mechanisms of formation and disintegration of alginate beads obtained by prilling 201
Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products 201
Fluorescent Multifunctional Organic Nanoparticles for Drug Delivery and Bioimaging: A Tutorial Review 194
Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma 192
Characterization of a polyurethane-based controlled release system for local delivery of chlorhexidine diacetate 191
CHIMERAL AGGLOMERATES OF MICRONIZED POWDER FOR NASAL ADMINISTRATION OF ANALGESIC DRUG 186
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 185
Intrapleural polymeric devices containing Cisplatin for malignant pleural Mesothelioma in a rat tumor model: a preliminary study. 184
Formulation of siRNA nanoparticles, transfection and enhanced adhesion -penetration in nasal mucosal tissue 183
Dynamics of water and small molecules in bioadhesive polymer films 183
Agglomerates of Morphine Microcrystals for Nasal or Buccal Administration 182
A NEW GASTRORETENTIVE DOSAGE FORM: FLOATING DOME MATRIX®. FORMULATION AND IN VITRO RELEASE STUDIES OF RIBOFLAVIN. 180
MULTILAYERED PHARMACEUTICAL FORMULATION 179
Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers 178
Therapeutic effect of cyclosporine A-loading TPGS micelles on a mouse model of LPS-induced neuroinflammation 177
Artesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination products 176
A dry powder formulation for peripheral lung delivery and absorption of an anti-SARS-CoV-2 ACE2 decoy polypeptide 175
Polysaccharides: New Frontiers for Nasal Administration of Medicines 175
Assemblage of novel release modules for the development of adaptable drug delivery systems 175
Application of quasi-elastic neutron scattering to the investigation of the dynamics and release properties of single-layer transdermal films containing lidocaine 175
PROGESTERONE LOADED LECITHIN/CHITOSAN NANOPARTICLES FOR TRANSMUCOSAL DELIVERY 175
Cell penetrating peptides in ocular drug delivery: State of the art 174
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 173
Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2 172
Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways 171
Cell culture studies of polysaccharide films loaded with cisplatin for the loco-regional therapy of malignant pleural mesothelioma 170
Intrapleural adjuvant treatment of mesothelioma : The combination of cisplatin-pemetrexed in rat tumor model 169
The effect of residual water on antacid activity of sucralfate gel dried by microwaves 168
Clyndamicin-Artesunate Combined Multi-Kinetics Drug Delivery System for Malaria Theraphy 168
Dynamics of lipid–saccharide nanoparticles by quasielastic neutron scattering 167
A Liposome-Micelle-Hybrid (LMH) Oral Delivery System for Poorly Water-Soluble Drugs: Enhancing Solubilisation and Intestinal Transport 167
Progesterone loading in lecithin/chitosan nanoparticles for transmucosal delivery 166
Design and Characterization of Maltoheptaose-b-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen 166
Effect of residual water content on the physico-chemical properties of sucralfate dried gel obtained by microwave drying 165
Chimerical agglomerates of lecithin/chitosan nanoparticles for powder nasal delivery 165
Preliminary Investigation on Simvastatin-Loaded Polymeric Micelles in View of the Treatment of the Back of the Eye 165
Mean square hydrogen fluctuations in chitosan/lecithin nanoparticles from elastic neutron scattering experiments 164
Assembled delivery modules for clarithromycin release in Helicobacter Pylori therapy 164
Dose administration manoeuvres and patient care in tobramycin dry powder inhalation therapy 164
Respicell(TM): An innovative dissolution apparatus for inhaled products 164
Nebulized coenzyme Q10 nanosuspensions: A versatile approach for pulmonary antioxidant therapy 163
Brain distribution of ribavirin after intranasal administration 162
"Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs 162
In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates 161
Structure of Self-Organized Multilayer Nanoparticles for Drug Delivery 159
High shear mixing of lactose and salmeterol xinafoate dry powder blends: biopharmaceutic and aerodynamic performances 159
Engineered sodium hyaluronate respirable dry powders for pulmonary drug delivery 159
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections 158
Gel-like TPGS-Based Microemulsions for Imiquimod Dermal Delivery: Role of Mesostructure on the Uptake and Distribution into the Skin 157
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: the enhancing effect of potassium sorbate 156
Chlorhexidine Salt-Loaded Polyurethane Orthodontic Chains: In Vitro Release and Antibacterial Activity Studies 156
The role of airways microbiota on local and systemic diseases: a rationale for probiotics delivery to the respiratory tract 155
A consensus research agenda for optimising nasal drug delivery 155
LACTOBACILLI INHALATION POWDER FOR THE REDUCTION OF LUNG INFLAMMATION IN non-CF BRONCHIECTASIS DISEASE 154
Flexibility and drug release features of lipid/saccharide nanoparticles 153
Assembled modules technology for site-specific prolonged delivery of norfloxacin 152
Therapeutic Paint of Cidofovir/Sucralfate Gel Combination Topically Administered by Spraying for treatment of Orf Virus Infections 152
Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats 152
Dome Matrix® technology : effect of drug solubility on release kinetics of swellable delivery modules 150
Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting 150
Chimeral agglomerates of microparticles for nasal administration of analgesic drug powders 149
Novel O/W nanoemulsions for nasal administration: Structural hints in the selection of performing vehicles with enhanced mucopenetration 149
Module assemblage technology for floating systems: in vitro flotation and in vivo gastro-retention 149
Ucuùba Fat Characterization and Use to Obtain Lipid Nanoparticles by High-Pressure Homogenization with Full Factorial Design 149
Nasal delivery as a strategy for the prevention and treatment of COVID-19 148
Les formes pharmaceutiques du futur 147
Crystallization of stable doped mannitol polymorphs and in vitro assessment of their safety as carriers for lung delivery 147
Lecithin-chitosan nanoparticles for transmucosal delivery of progesterone via chimerical agglomerates 145
New modules, new assembly kits and new assembles for controlled release of substances 141
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays 141
Single layer transdermal film containing lidocaine: water and lidocaine mobility determined using neutron scattering 141
Hyaluronate nanoparticles included in polymer films for the prolonged release of vitamin E for the management of skin wounds 141
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs 140
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 139
Fluorescence-enabled evaluation of nasal tract deposition and coverage of pharmaceutical formulations in a silicone nasal cast using an innovative spray device 138
Modular systems fitted together for the controlled release of substances 138
Development and validation of a RP-HPLC method for the simultaneous detection and quantification of simvastatin's isoforms and coenzyme Q10 in lecithin/chitosan nanoparticles 137
From tablets to pharmaceutical nanotechnologies: Innovation in drug delivery strategies for the administration of antimalarial drugs 137
IN13 Backscattering Spectrometer at ILL: Looking for Motions in Macromolecules and Organisms 136
Cell-Penetrating Peptide-Decorated Nanovectors for Nose-to-Brain Delivery: A New Treatment Option for CNS Diseases 135
Totale 18.084
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.070
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.070
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022900 0 0 0 66 45 61 98 103 50 71 55 351
2022/20233.549 367 386 220 258 287 361 37 259 1.192 31 107 44
2023/20241.636 86 129 40 62 115 359 222 126 47 100 138 212
2024/20255.143 124 256 330 395 505 635 288 207 601 475 438 889
2025/202611.204 959 877 1.326 945 1.512 555 1.189 352 1.436 932 648 473
2026/20273.407 847 800 760 1.000 0 0 0 0 0 0 0 0
Totale 30.804